Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN vs NARATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN vs NARATRIPTAN: Safety Overview

Metric NAPROXEN NARATRIPTAN
Total FAERS Reports 52,751 526
Deaths Reported 5,127 9
Death Rate 9.7% 1.7%
Hospitalizations 12,849 102
Average Patient Age 55.0 yrs 49.2 yrs
% Female Patients 71.5% 90.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 22, 2011
Manufacturer Aurobindo Pharma Limited Hikma Pharmaceuticals USA Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued